Dr. Joao de Quevedo with UTHealth Houston shares what researchers found during a clinical trial for Spravato, the first FDA-approved nasal spray to treat depression. Elizabeth Warren tells Elon ...
This new treatment could help bring relief for millions of Americans struggling with depression. The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for ...
Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...
Researchers delivered a dose of the “love hormone” oxytocin via a nasal spray to participants and found that it decreased ...
A government-wide hiring freeze and halt to funding of travel, meetings and communications have officials at the National ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback